Eyconis
Eyconis, Inc. is a privately held, pre-clinical stage biopharmaceutical company focused on transforming the ophthalmology treatment paradigm through the development, manufacture, and commercialization of novel, best-in-class therapeutics for eye diseases. The Company is advancing a pipeline of therapeutic candidates addressing areas of high unmet need including wet age-related macular degeneration (AMD). Eyconis is partnered with a syndicate of leading biopharma investors including Frazier Life Sciences, RA Capital Management, venBio Partners, and HealthQuest Capital. The Company is headquartered in Redwood City, California, including research & development laboratories with scientific and manufacturing team members.
eyconis.comCompany Details
Founded
- 2024
Employees
- Between 10 - 50 employees
Raised
- $60,251,248
Public
- No
Acquired
- No
CEO
Mark J. Bachleda
Founders
- Emmett Cunningham
Company Collections
These are collections Eyconis is a part of. Click on the collection name to view similar companies.